Cloverfields Capital Group, LP Novartis Ag Transaction History
Cloverfields Capital Group, LP
- $271 Million
- Q1 2025
A detailed history of Cloverfields Capital Group, LP transactions in Novartis Ag stock. As of the latest transaction made, Cloverfields Capital Group, LP holds 19,295 shares of NVS stock, worth $2.23 Million. This represents 0.79% of its overall portfolio holdings.
Number of Shares
19,295
Previous 19,378
0.43%
Holding current value
$2.23 Million
Previous $1.89 Million
14.11%
% of portfolio
0.79%
Previous 0.68%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...